Cargando…

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series

INTRODUCTION: mRNA coronavirus disease 2019 (COVID-19) vaccination has been widely used to arrest the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Rarely, autoimmune events such as relapses in patients with multiple sclerosis (MS) have been reported after vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quintanilla-Bordás, Carlos, Gascón-Gimenez, Francisco, Alcalá, Carmen, Payá, María, Mallada, Javier, Silla, Raquel, Carratalà-Boscà, Sara, Gasque-Rubio, Raquel, Castillo, Jessica, Casanova, Bonaventura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091902/ https://www.ncbi.nlm.nih.gov/pubmed/35572939 http://dx.doi.org/10.3389/fneur.2022.897275

Ejemplares similares

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
por: Castillo-Villalba, Jéssica, et al.
Publicado: (2022)

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
por: Alcalá Vicente, Carmen, et al.
Publicado: (2022)

Escalation vs. Early Intense Therapy in Multiple Sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2022)

Potential Role of CHI3L1+ Astrocytes in Progression in MS
por: Cubas-Núñez, Laura, et al.
Publicado: (2021)

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype
por: Cantó, Laura Navarro, et al.
Publicado: (2019)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
por: Gil-Perotin, Sara, et al.
Publicado: (2019)

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report
por: Gil-Perotin, Sara, et al.
Publicado: (2018)

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain
por: Landete, Lamberto, et al.
Publicado: (2021)

Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience
por: Gascón-Giménez, Francisco, et al.
Publicado: (2023)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Rituximab: Relapse or exacerbation of COVID-19 pneumonia: 4 case reports
Publicado: (2022)

mrna-1273: Exacerbation of chronic obstructive pulmonary disease: case report
Publicado: (2021)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

CSF chitinase 3-like-1 association with disability of primary progressive MS
por: Pérez-Miralles, Francisco, et al.
Publicado: (2020)

mRNA-1273: Exacerbation of chronic inflammatory demyelinating polyneuropathy: case report
Publicado: (2021)

mRNA-1273/tozinameran: Autoimmune haemolytic anaemia relapse and immune thrombocytopenia relapse: 8 case reports
Publicado: (2021)

mRNA-1273: Relapsed acquired thrombotic thrombocytopenic purpura: case report
Publicado: (2022)

Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine
por: Fyfe, Ian
Publicado: (2021)

Differential expression of mRNA isoforms in the skeletal muscle of pigs with distinct growth and fatness profiles
por: Cardoso, Tainã Figueiredo, et al.
Publicado: (2018)

mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis
por: Blanco, Yolanda, et al.
Publicado: (2023)

Acute exacerbations of COPD: risk factors for failure and relapse
por: Mantero, Marco, et al.
Publicado: (2017)

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life
por: Planas, Raquel, et al.
Publicado: (2014)

Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis
por: Hanioka, Yusuke, et al.
Publicado: (2020)

Variability in porcine microRNA genes and its association with mRNA expression and lipid phenotypes
por: Mármol-Sánchez, Emilio, et al.
Publicado: (2021)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

In situ RT-PCR Optimized for Electron Microscopy Allows Description of Subcellular Morphology of Target mRNA-Expressing Cells in the Brain
por: Cubas-Nuñez, Laura, et al.
Publicado: (2017)

Nutrient supply affects the mRNA expression profile of the porcine skeletal muscle
por: Cardoso, Tainã Figueiredo, et al.
Publicado: (2017)

mRNA-1273/salbutamol: Exacerbation of chronic obstructive pulmonary disease and lack of efficacy: case report
Publicado: (2021)

Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
por: Meca-Lallana, José E., et al.
Publicado: (2023)

Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study
por: Barrero, Francisco, et al.
Publicado: (2020)

ACTH gel in the treatment of multiple sclerosis exacerbation: a case study
por: Napoli, Salvatore
Publicado: (2015)

Covid-19-vaccine: Relapse of multiple sclerosis: case report
Publicado: (2022)

mRNA-1273/warfarin: Exacerbation of preexisting IgA nephropathy and gross haematuria: 2 case reports
Publicado: (2021)

A Case of Takotsubo Cardiomyopathy Triggered by Asthma Exacerbation After mRNA-based Vaccination for COVID-19
por: Tachibana, Yusuke, et al.
Publicado: (2023)

Influenza-virus-vaccine/mRNA-1273/tozinameran: Glomerulonephritis and relapse of glomerulonephritis: 13 case reports
Publicado: (2022)

The Factors Influencing Relapse in Patients Presenting to the Emergency Department with COPD Exacerbation
por: DURMAZ, Dilek, et al.
Publicado: (2016)

Incidence and baseline characteristics of relapse or exacerbation in patients with pulmonary sarcoidosis in Japan
por: Murata, Okinori, et al.
Publicado: (2021)

Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study)
por: Fernández, Oscar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m9r78i9k7dfhujti9tksvv2aqc